| __timestamp | Amphastar Pharmaceuticals, Inc. | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 17990000 |
| Thursday, January 1, 2015 | 46974000 | 25166000 |
| Friday, January 1, 2016 | 47298000 | 27013000 |
| Sunday, January 1, 2017 | 50918000 | 42383000 |
| Monday, January 1, 2018 | 58044000 | 57012000 |
| Tuesday, January 1, 2019 | 63109000 | 66546000 |
| Wednesday, January 1, 2020 | 65157000 | 77238000 |
| Friday, January 1, 2021 | 68920000 | 105445000 |
| Saturday, January 1, 2022 | 66592000 | 156190000 |
| Sunday, January 1, 2023 | 80393000 | 169610000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, effective cost management is crucial. Amphastar Pharmaceuticals, Inc. and Evotec SE, two prominent players, have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Amphastar's SG&A expenses grew by approximately 99%, reflecting a strategic expansion and investment in operational capabilities. Meanwhile, Evotec SE's expenses surged by an impressive 843%, indicating a robust scaling of their business operations.
These trends highlight the dynamic nature of cost management strategies in the pharmaceutical industry.
Vertex Pharmaceuticals Incorporated vs Evotec SE: SG&A Expense Trends
Selling, General, and Administrative Costs: argenx SE vs Evotec SE
Operational Costs Compared: SG&A Analysis of Biogen Inc. and Amphastar Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Amphastar Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Evotec SE
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Evotec SE
Selling, General, and Administrative Costs: BioMarin Pharmaceutical Inc. vs Evotec SE
Comparing SG&A Expenses: Alkermes plc vs Evotec SE Trends and Insights
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Arrowhead Pharmaceuticals, Inc. and Evotec SE
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and Evotec SE
SG&A Efficiency Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Travere Therapeutics, Inc.